Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATR | Q13535 | 1/20 | 0.33 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.32 |
| ▸ | JAK2 | O60674 | 1/20 | 0.31 |
| ▸ | JAK3 | P52333 | 1/20 | 0.31 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31423965 | 0.90 | MAPK8 (0.33) | ATRMAPK8JAK2JAK3PTK2 | |
| SCHEMBL31423883 | 0.88 | MAPK8 (0.33) | ATRMAPK8JAK2JAK3PTK2 | |
| SCHEMBL31423962 | 0.88 | MAPK8 (0.33) | ATRMAPK8JAK2JAK3PTK2 | |
| SCHEMBL31423901 | 0.84 | MAPK8 (0.32) | MAPK8JAK2JAK3PTK2 | |
| SCHEMBL31423905 | 0.82 | MAPK8 (0.40) | MAPK8JAK2JAK3PTK2MEN1 | |
| SCHEMBL31423976 | 0.82 | MAPK8 (0.32) | MAPK8JAK2JAK3PTK2 | |
| SCHEMBL31423908 | 0.82 | MAPK8 (0.32) | MAPK8JAK2JAK3PTK2 | |
| SCHEMBL31423988 | 0.82 | MAPK8 (0.32) | MAPK8JAK2JAK3PTK2 | |
| SCHEMBL31423978 | 0.81 | JAK2 (0.37) | JAK2JAK3 | |
| SCHEMBL31423886 | 0.80 | MAPK8 (0.33) | ATRMAPK8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025054386-A1 | CDK2 INHIBITORS AND USES THEREOF | ODYSSEY THERAPEUTICS, INC. (US) | 2025-03-13 | — | — | WO | disclosed |